FOLFIRINOX Chemotherapy in Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Retrospective and Phase II Studies

The introduction of the FOLFIRINOX regimen within the last decade marked the first progress in the clinical field of metastatic pancreatic cancer which had not seen any improvements in treatment availability for several years. In a phase III randomized clinical trial, FOLFIRINOX showed superior effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thibodeau, Stephane, Voutsadakis, Ioannis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791015/
https://www.ncbi.nlm.nih.gov/pubmed/29300345
http://dx.doi.org/10.3390/jcm7010007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791015/
https://www.ncbi.nlm.nih.gov/pubmed/29300345
http://dx.doi.org/10.3390/jcm7010007

Ejemplares similares